FUT10 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT11 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT2 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT3 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT4 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT5 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT6 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT7 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT8 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUT9 Human Pre-designed siRNA Set A contains three designed siRNAs for FUT9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FUZ Human Pre-designed siRNA Set A contains three designed siRNAs for FUZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXIIa-IN-3 (Compound 8) is a potent and selective Factor XIIa (FXIIa) inhibitor, with an IC50 of 0.045 μM. FXIIa-IN-3 also exhibits a substantial margin of selectivity against related serine proteases, including FXIa, FXa, and FIXa. FXIIa-IN-3 can be used for the research of thromboembolic diseases[1].

FXIIa-IN-4 (compound 22) is a potent, selective human FXIIa inhibitor with the IC50 of 0.032 μM, 0.30 μM, ＞50 μM for FXIIa, thrombin and FXIa, respectively. FXIIa-IN-4 can be used for study of anticoagulant[1].

FXN Human Pre-designed siRNA Set A contains three designed siRNAs for FXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXR agonist 7 (compound 33) is a potent agonist of FXR, with EC50 of 0.1 nM. FXR agonist 7 shows high intestinal distribution, good anti-inflammatory activity[1].

FXR1 Human Pre-designed siRNA Set A contains three designed siRNAs for FXR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXR2 Human Pre-designed siRNA Set A contains three designed siRNAs for FXR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD2 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD3 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD4 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD5 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD6 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FXYD7 Human Pre-designed siRNA Set A contains three designed siRNAs for FXYD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FYB1 Human Pre-designed siRNA Set A contains three designed siRNAs for FYB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FYCO1 Human Pre-designed siRNA Set A contains three designed siRNAs for FYCO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FYN Human Pre-designed siRNA Set A contains three designed siRNAs for FYN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FYTTD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FYTTD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD10 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD2 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD3 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD4 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD5 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD6 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD7 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD8 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZD9 Human Pre-designed siRNA Set A contains three designed siRNAs for FZD9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FZR1 Human Pre-designed siRNA Set A contains three designed siRNAs for FZR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

G-quadruplex ligand 2 (compound A3) is a triphenylamine-based ligand that targets mitochondrial DNA G4s. G-quadruplex ligand 2 activates the cGAS-STING pathway. G-quadruplex ligand 2 inhibits tumor growth and metastasis via regulation of TME[1].

G0S2 Human Pre-designed siRNA Set A contains three designed siRNAs for G0S2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

G1-OC2-K3-E10 is an ionizable lipid, and can be used for delivery of mRNA in lipid nanoparticles (LNPs)[1].

G2E3 Human Pre-designed siRNA Set A contains three designed siRNAs for G2E3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

G3BP1 Human Pre-designed siRNA Set A contains three designed siRNAs for G3BP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

G3BP2 Human Pre-designed siRNA Set A contains three designed siRNAs for G3BP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.